Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
29-30 March, 2025
Not Confirmed
Not Confirmed
31 March-01 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
29-30 March, 2025
Industry Trade Show
Not Confirmed
31 March-01 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
27 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/27/3034272/0/en/Denali-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Business-Highlights.html
06 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/06/3022238/0/en/Denali-Therapeutics-Announces-Primary-Analysis-and-Long-Term-Follow-Up-of-Phase-1-2-Study-in-Hunter-Syndrome-MPS-II-with-Tividenofusp-Alfa.html
30 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/30/3018009/0/en/Denali-Therapeutics-Announces-Upcoming-Presentations-on-Hunter-Syndrome-MPS-II-and-TransportVehicle-Enabled-Investigational-Therapeutic-Tividenofusp-Alfa-at-the-2025-WORLDSymposium.html
13 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/13/3008476/0/en/Denali-Therapeutics-Announces-Key-Anticipated-2025-Milestones-and-Priorities-to-Further-Advance-Its-Therapeutics-Portfolio-for-Neurodegeneration-and-Lysosomal-Storage-Diseases.html
10 Jan 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/arch-backed-tenvie-unveils-200m-and-neuro-pipeline-assets-denali
08 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/08/3006194/0/en/Denali-Therapeutics-Announces-U-S-FDA-Breakthrough-Therapy-Designation-Granted-to-Tividenofusp-Alfa-for-the-Treatment-of-Hunter-Syndrome-MPS-II.html
ABOUT THIS PAGE